• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,488.96 1,073.61
( 1.42%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
65,182.04 1,842.97
(2.91%)
Nikkei 225
10,466.26 22.79
(0.22%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.385578
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
30.54
113007.26
EPS(TTM)
Face Value()
Div & Yield %
45.81
2
0.93
 

NDL Ventures standalone net profit rises 7.14% in the March 2026 quarter
Apr 21,2026
Net profit of NDL Ventures rose 7.14% to Rs 0.15 crore in the quarter ended March 2026 as against Rs 0.14 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 54.24% to Rs 0.91 crore in the year ended March 2026 as against Rs 0.59 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.